Androgen Receptor Inhibitors

Androgen receptor inhibitors are pharmaceutical compounds that specifically target and inhibit the function of the androgen receptor (AR). The AR is a nuclear receptor protein that plays a crucial role in mediating the biological effects of androgen hormones like testosterone and dihydrotestosterone. By binding to the androgen receptor and preventing its activation by androgens, these inhibitors disrupt the AR signaling pathway, thereby suppressing the transcription of androgen-responsive genes involved in cell growth, differentiation, and survival. Clinically, androgen receptor inhibitors are used in the treatment of hormone-sensitive cancers, particularly prostate cancer, where blocking AR signaling can slow tumor growth and progression.